Evidence map›Paper›PMID 31973133›Full record

ArticleMolecules (Basel, Switzerland)2020

Treatment of Human Lens Epithelium with High Levels of Nanoceria Leads to Reactive Oxygen Species Mediated Apoptosis.

Belal I Hanafy, Gareth W V Cave, Yvonne Barnett, Barbara Pierscionek

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Mechanistic insights intoToxicology research · 2024
    Article
  3. Review
  4. Plants (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Anti-Inflammatory CeOMolecules (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Belal I HanafySchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.ORCID 0000-0001-5356-8458
Gareth W V CaveSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Yvonne BarnettSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Barbara PierscionekSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Nottingham Trent University · GBAnglia Ruskin University · GBUniversity of Staffordshire · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoceria (cerium oxide nanoparticles) have been shown to protect human lens epithelial cells (HLECs) from oxidative stress when used at low concentrations. However, there is a lack of understanding about the mechanism of the cytotoxic and genotoxic effects of nanoceria when used at higher concentrations. Here, we investigated the impact of 24-hour exposure to nanoceria in HLECs. Nanoceria's effects on basal reactive oxygen species (ROS), mitochondrial morphology, membrane potential, ATP, genotoxicity, caspase activation and apoptotic hallmarks were investigated. Scanning electron microscopy-energy dispersive X-ray spectroscopy (SEM-EDX) studies on isolated mitochondria revealed significant uptake and localization of nanoceria in the mitochondria. At high nanoceria concentrations (400 µg mL

Indexed as

Adenosine TriphosphateApoptosisCaspase 3Caspase 7CeriumDNA DamageEpithelial CellsEpitheliumEthylene GlycolHumansLens, CrystallineMembrane Potential, MitochondrialMitochondriaMutagensNanoparticlesReactive Oxygen SpeciesAdenosine TriphosphateCaspase 3Caspase 7ceric oxideCeriumEthylene GlycolMutagensReactive Oxygen Speciesapoptosiscerium oxidegenotoxicitymitochondriareactive oxygen species

Identifiers

PMID31973133
PMCPMC7036910
OpenAlexW3001661961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.